About: Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) article scientifique publié en 2000 (fr) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59305087-9C49DABE-97B6-496F-BB98-D38E98CC72B3
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59305087-2076875E-DE0D-4BD8-846B-7925904A69E0
language of work or name	English
author name string	wds:Q59305087-0009451F-FFB4-4719-8A02-8FC0922D3E59 wds:Q59305087-1A2A80FE-B987-4B37-B1FD-B84A903DD0B2 wds:Q59305087-2B80318B-09D2-41CE-AEBF-04B4D1AED27A wds:Q59305087-81575013-9A72-4DD4-B0FC-125159EB25A8 wds:Q59305087-A0078B15-D9FB-484C-B5BA-DAC3462E15E0 wds:Q59305087-A62738A3-4C22-4315-BB08-058C9B4BD463 wds:Q59305087-AC99CC9B-51C0-4E25-8B82-85DEC0121B37 wds:Q59305087-BC11FFEE-F28D-4264-96EA-4C06954F524B wds:Q59305087-DE900ED1-31C9-4DBE-B136-B8AC5B8D8202
author name string	J Verweij I R Judson R Coleman D Tonelli M van Glabbeke W Ruka J Buesa E D di Paola R van Hoessel
rdfs:label	Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (en) Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (nl)
skos:prefLabel	Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (en) Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (nl)
name	Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (en) Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue (nl)
author	wds:Q59305087-006D2A68-E969-4629-8BD8-B333A26128B5 wds:Q59305087-CCE5694B-5BAA-4D5B-A763-33AF827F7081
author	Caroline Seynaeve Siow-Ming Lee
title	wds:Q59305087-E5C1076B-BF96-498F-960E-7F91DF2501A7
title	Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group (en)
page(s)	wds:Q59305087-E0278EB5-43AF-4FEE-A7E3-0E3D9DFCAAE3
page(s)	2081-2086
instance of	wds:Q59305087-5DEC0CD3-8B4A-4FC0-83F8-9A068567F53A
instance of	scholarly article
main subject	wds:Q59305087-1AB2A619-388E-45D1-8986-F5B99FF6047B wds:Q59305087-85A85A71-EC04-451B-8908-CD8B7F2AF44A wds:Q59305087-BAEE08DB-0646-46BB-A4F7-0A6A4318982D
main subject	wd:Q18936 wd:Q420436 chemotherapy
PubMed ID	wds:Q59305087-C7F40BA8-5661-4641-8288-11BBFEA4A9BF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10811673
PubMed ID	10811673
published in	wds:Q59305087-D23EB627-6EF7-4BA6-913D-971469ED153A
published in	Journal of Clinical Oncology
issue	wds:Q59305087-65CFB799-6A61-478D-901F-35E4C6C83143
volume	wds:Q59305087-39189FCD-20FE-4DCF-AA4E-882D73B23367
issue	10
volume	18
DOI	wds:Q59305087-AD79F8A3-7376-4D98-A40C-3C4BA2FCA67B
DOI	http://dx.doi.org/10.1200/JCO.2000.18.10.2081
DOI	10.1200/JCO.2000.18.10.2081
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59305087
is cites work of	Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines. Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials. Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future Management of angiosarcoma Angiosarcoma Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine origin Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. The treatment of uterine sarcomas Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas Prostate angiosarcoma: is there any association with previous radiation therapy? Radiation-induced sarcoma of the breast: a systematic review Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma Long-term survival of a patient with scalp angiosarcoma and multiple metastases treated using combination therapy: A case report Chemotherapy for soft tissue sarcoma Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate Histology-driven chemotherapy in soft tissue sarcomas Surrogate endpoints in advanced sarcoma trials: a meta-analysis Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients Targeted therapy for soft tissue sarcomas in adolescents and young adults Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma Angiosarcomas and taxanes

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software